Target intelligence / Profile preview

Novel transcript, antisense to HKR1

Molecular classification: Other (Antisense non-coding RNA)

Overview

This "novel transcript, antisense to HKR1" (ENSG00000276846) is classified as a non-coding RNA transcript located antisense to the coding gene HKR1. Its sequence is present in the human genome but is not known to encode a protein or to have a defined molecular function, biological process, or disease relevance. It is cataloged as a genomic annotation, not as a characterized molecule or therapeutic target. There are no aliases suggestive of a functional product, and no associated drugs, mechanisms of action, or biomarker data[1].

Other names: ENSG00000276846antisense to HKR1[1]

Beyond the preview

Go deeper on Novel transcript, antisense to HKR1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to HKR1.

Explore the full profile